Vera Therapeutics, Inc. Class A (VERA)
NASDAQ · Manufacturing · Pharmaceutical preparations
$32.75−$0.5900 (−1.77%) on the dayAs of the close; data may be delayed.
VERA price, last 12 months
Key stats
- Previous close
- $33.34
- Open
- $33.40
- Day range
- $32.46 – $33.70
- 52-week range
- $23.05 – $56.05
- Volume
- 1.1M
- Avg volume (20 days)
- 2.6M
- Market cap
- $2.3B
Performance
1W−3.7%
1M−11.1%
3M−22.9%
6M−18.7%
YTD−35.3%
1Y+25.3%
vs S&P 500, 1Y+8.5 pts
Technicals and fundamentals
About Vera Therapeutics, Inc. Class A
Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.
- Sector
- Manufacturing
- Industry
- Pharmaceutical preparations
- Listed on
- NASDAQ
- Market cap
- $2.3B